Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetylcholine (ACh) release refers to the process by which the neurotransmitter acetylcholine is secreted from nerve terminals into synaptic clefts, enabling communication between neurons or between neurons and muscle cells. This process is fundamental for both central and peripheral nervous system function, mediating voluntary muscle movement, autonomic regulation, and various cognitive processes. Release is triggered by calcium influx into presynaptic terminals, leading to exocytosis of ACh-containing vesicles. The process is regulated by presynaptic receptors. Termination of action occurs via acetylcholinesterase. Drugs and toxins can modulate this process, impacting various diseases.
Modulation of acetylcholine release via presynaptic mechanisms or affecting acetylcholinesterase activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine Release.